Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M206,836Revenue $M49,605Net Margin (%)18.7Altman Z-Score2.8
Enterprise Value $M215,364EPS $1.4Operating Margin %25.9Piotroski F-Score6
P/E(ttm)23.3Beneish M-Score-2.7Pre-tax Margin (%)25.4Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %3.0Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %5.0Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow16.5y-y EBITDA Growth Rate %-14.2ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %3.2PEG4.6ROE % (ttm)12.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,158ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2015-06-11Sell26,000$34.39-2.33view
HILL CHARLES HExecutive Vice President 2015-05-29Sell42,870$34.92-3.81view
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$34-1.21view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.62-2.98view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.46-2.52view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.73-3.28view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.85-3.62view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.23-1.87view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.3-2.07view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.78-0.56view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Despite Recent Downgrade, This Ecommerce Giant is a Buy Jun 29 2015 
    Paul Tudor Jones' Top Three Stocks Deliver Positive Returns Jun 24 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    A Look at James Barrow's Investment in Pfizer Jun 16 2015 
    Jim Simons' Top 3 Positions and One That Doubled Return Jun 10 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 
    Ken Fisher Adds to His Pfizer Position May 27 2015 
    Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
    Amgen’s Cholesterol Fighting Drug Receives EU Approval May 26 2015 

    More From Other Websites
    Bank controls add to headaches for Greece's pharmacists Jun 29 2015
    Bank controls add to headaches for Greece's pharmacists Jun 29 2015
    Dow falls 225 points, in the red for the year amid Greece; VIX spikes 24% Jun 29 2015
    Drugmakers warn Greek medicine supply "may be in jeopardy" Jun 29 2015
    Is Big Pharma Advertising Getting Out of Control? Jun 26 2015
    Valeant Pharmaceuticals And Zoetis: A True Mega Deal Is On The Horizon Jun 26 2015
    Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog Jun 25 2015
    Zoetis Shares Surge After Report of Takeover Approach by Valeant Jun 25 2015
    Pfizer Declares 28-Cent Third-Quarter 2015 Dividend Jun 25 2015
    Joseph J. Echevarria Elected To Pfizer’s Board Of Directors Jun 25 2015
    Joseph J. Echevarria Elected To Pfizer’s Board Of Directors Jun 25 2015
    Pfizer Declares 28-Cent Third-Quarter 2015 Dividend Jun 25 2015
    Lilly Blooms; Shares Up 4.5% on Patent Win, Merrill Upgrade Jun 25 2015
    Short Sellers Become More Focused on Big Pharma Jun 25 2015
    America's top states for innovation in 2015 Jun 24 2015
    U.S. CDC updates recommendation for new meningitis B vaccines Jun 24 2015
    U.S. CDC updates recommendation for new meningitis B vaccines Jun 24 2015
    Pfizer (PFE) Stock Falling on Study Possibly Linking Viagra to Melanoma Jun 24 2015
    Traders see money in this drug stock Jun 24 2015
    Paul Tudor Jones' Top Three Stocks Deliver Positive Returns Jun 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 1 year ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK